Mark Zuckerberg-Backed AI Startup Takes Over Parkinson’s Treatment From the Maker of Ozempic (opens in new tab)
Cellular Intelligence just acquired the rights to an experimental Parkinson’s cell therapy from Novo Nordisk.
Read the original articleCellular Intelligence just acquired the rights to an experimental Parkinson’s cell therapy from Novo Nordisk.
Read the original article